1 |
(r)-[n-metil-11c1-pk11195(pk) |
- |
- |
- |
- |
127 1件: 127 💬 |
2 |
18f-av-1451 |
- |
- |
- |
- |
005 3件: 5 , 7 , 127 💬 |
3 |
18f-av-45 |
- |
- |
- |
- |
006 2件: 6 , 127 💬 |
4 |
18f-fdg |
Fludeoxyglucose (18F) |
- |
- |
- |
005 12件: 5 , 6 , 7 , 13, 41, 46, 53, 84, 85, 96, 127, 300 💬 |
5 |
18f-ro6958948 |
- |
- |
- |
- |
005 3件: 5 , 7 , 127 💬 |
6 |
[18f]pi-2620 |
- |
- |
- |
- |
006 2件: 6 , 127 💬 |
7 |
Al |
- |
- |
- |
- |
005 9件: 5 , 6 , 7 , 28, 51, 67, 86, 114, 127 💬 |
8 |
Al001 |
- |
- |
- |
- |
127 1件: 127 💬 |
9 |
Amantadine |
Amantadine |
2件: D00777 D00777, D07441 D07441 💬 |
GRIN1 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
006 4件: 6 , 8 , 13, 127 💬 |
10 |
Amiodarone |
Amiodarone |
2件: D00636 D00636, D02910 D02910 💬 |
ADRA1A 16件: ADRA1A, ADRA1B, ADRA1D, ADRB1, KCND3, KCNJ11, KCNJ12, KCNJ3, KCNJ5, KCNJ8, KCNQ1, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
AMPK signaling pathway 31件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Dilated cardiomyopathy, Dopaminergic synapse, Estrogen signaling pathway, Gap junction, Gastric acid secretion, Glutamatergic synapse, GnRH secretion, Insulin secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, Pancreatic secretion, Protein digestion and absorption, Regulation of lipolysis in adipocytes, Renin secretion, Retrograde endocannabinoid signaling, Salivary secretion, Serotonergic synapse, Spinocerebellar ataxia, Taste transduction, Type II diabetes mellitus, Vascular smooth muscle contraction, Vibrio cholerae infection, cAMP signaling pathway, cGMP-PKG signaling pathway |
028 2件: 28, 127 💬 |
11 |
Amyvid |
- |
- |
- |
- |
013 2件: 13, 127 💬 |
12 |
Behavioral: cognitive and behavioral experimental tasks |
- |
- |
- |
- |
006 2件: 6 , 127 💬 |
13 |
Behavioral: ecocapture |
- |
- |
- |
- |
006 2件: 6 , 127 💬 |
14 |
Behavioral: icm_apathy_tasks |
- |
- |
- |
- |
006 2件: 6 , 127 💬 |
15 |
Biib092 |
- |
- |
- |
- |
005 3件: 5 , 7 , 127 💬 |
16 |
C-11 pib |
Pittsburgh Compound B |
- |
- |
- |
127 1件: 127 💬 |
17 |
Carbonate |
Carbonate ion |
- |
- |
- |
002 12件: 2 , 13, 17, 18, 19, 46, 53, 75, 96, 127, 235, 299 💬 |
18 |
Chloride |
Chloride ion |
- |
- |
- |
006 25件: 6 , 11, 13, 14, 34, 46, 50, 51, 53, 60, 65, 78, 96, 97, 127, 168, 171, 193, 227, 228, 271, 288, 296, 297, 299 💬 |
19 |
Citalopram |
Citalopram |
2件: D00822 D00822, D07704 D07704 💬 |
SLC6A4 1件: SLC6A4 💬 |
Serotonergic synapse 2件: Serotonergic synapse, Synaptic vesicle cycle |
006 6件: 6 , 8 , 13, 18, 46, 127 💬 |
20 |
Davunetide |
Davunetide |
1件: D09401 D09401 💬 |
- |
- |
005 3件: 5 , 7 , 127 💬 |
21 |
Davunetide (al-108, nap) |
Davunetide |
1件: D09401 D09401 💬 |
- |
- |
005 3件: 5 , 7 , 127 💬 |
22 |
Diagnostic test: [18f]-ro6958948 |
- |
- |
- |
- |
005 5件: 5 , 6 , 7 , 17, 127 💬 |
23 |
Diagnostic test: elecsys (roche) abeta42, ttau and ptau |
- |
- |
- |
- |
005 5件: 5 , 6 , 7 , 17, 127 💬 |
24 |
Diagnostic test: flutemetamol f18 injection |
Flutemetamol |
1件: D10231 D10231 💬 |
- |
- |
005 5件: 5 , 6 , 7 , 17, 127 💬 |
25 |
Diagnostic test: lumipulse (fujirebio) abeta42, ttau and ptau |
- |
- |
- |
- |
005 5件: 5 , 6 , 7 , 17, 127 💬 |
26 |
Diagnostic test: neuropsychological assessment |
- |
- |
- |
- |
006 2件: 6 , 127 💬 |
27 |
Diagnostic test: supplementary neuropsychological assessment - parkinson's disease |
- |
- |
- |
- |
006 2件: 6 , 127 💬 |
28 |
Donepezil |
Donepezil |
2件: D00670 D00670, D07869 D07869 💬 |
ACHE 1件: ACHE 💬 |
Cholinergic synapse 2件: Cholinergic synapse, Glycerophospholipid metabolism |
005 9件: 5 , 6 , 13, 46, 78, 124, 127, 156, 206 💬 |
29 |
Evp-0334 |
- |
- |
- |
- |
127 1件: 127 💬 |
30 |
F 18 t807 |
- |
- |
- |
- |
127 1件: 127 💬 |
31 |
F-18 |
- |
- |
- |
- |
005 2件: 5 , 127 💬 |
32 |
F-18 fdg |
- |
- |
- |
- |
127 1件: 127 💬 |
33 |
Ferulic acid |
Ferulic acid |
- |
- |
- |
127 1件: 127 💬 |
34 |
Florbetapir (18f) |
- |
- |
- |
- |
127 1件: 127 💬 |
35 |
Florbetapir 18f |
- |
- |
- |
- |
127 1件: 127 💬 |
36 |
Florbetapir 18f injection |
- |
- |
- |
- |
127 1件: 127 💬 |
37 |
Flortaucipir |
Flortaucipir |
1件: D11210 D11210 💬 |
- |
- |
005 3件: 5 , 7 , 127 💬 |
38 |
Flortaucipir f18 |
Flortaucipir |
1件: D11210 D11210 💬 |
- |
- |
005 3件: 5 , 7 , 127 💬 |
39 |
Flutemetamol |
Flutemetamol |
- |
- |
- |
005 5件: 5 , 6 , 7 , 17, 127 💬 |
40 |
Flutemetamol f18 |
Flutemetamol |
1件: D10231 D10231 💬 |
- |
- |
005 5件: 5 , 6 , 7 , 17, 127 💬 |
41 |
Frm-0334 |
- |
- |
- |
- |
127 1件: 127 💬 |
42 |
Galantamine |
Galantamine |
2件: D02173 D02173, D04292 D04292 💬 |
ACHE 1件: ACHE 💬 |
Cholinergic synapse 2件: Cholinergic synapse, Glycerophospholipid metabolism |
006 2件: 6 , 127 💬 |
43 |
Galantamine hydrobromide |
Galantamine |
2件: D02173 D02173, D04292 D04292 💬 |
ACHE 1件: ACHE 💬 |
Cholinergic synapse 2件: Cholinergic synapse, Glycerophospholipid metabolism |
127 1件: 127 💬 |
44 |
Histone deacetylase inhibitor |
- |
- |
- |
- |
127 1件: 127 💬 |
45 |
Intranasal oxytocin |
Oxytocin |
1件: D00089 D00089 💬 |
OXTR 1件: OXTR 💬 |
Calcium signaling pathway 4件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway |
127 2件: 127, 193 💬 |
46 |
Leucine |
Leucine |
1件: D00030 D00030 💬 |
- |
- |
005 10件: 5 , 6 , 7 , 19, 96, 97, 127, 283, 284, 299 💬 |
47 |
Leuco-methylthioninium bis(hydromethanesulfonate) |
Methylthioninium |
- |
- |
- |
127 1件: 127 💬 |
48 |
Lithium carbonate |
Carbonate ion |
1件: D00801 D00801 💬 |
- |
- |
002 6件: 2 , 13, 17, 18, 19, 127 💬 |
49 |
Lmtm |
- |
- |
- |
- |
127 1件: 127 💬 |
50 |
Lmtm/trx0237 |
- |
- |
- |
- |
127 1件: 127 💬 |
51 |
Memantine |
Memantine |
2件: D04905 D04905, D08174 D08174 💬 |
GRIN1 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
002 7件: 2 , 6 , 8 , 13, 49, 127, 205 💬 |
52 |
Memantine hydrochloride |
Memantine |
2件: D04905 D04905, D08174 D08174 💬 |
GRIN1 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
002 3件: 2 , 6 , 127 💬 |
53 |
Metformin |
Metformin |
2件: D00944 D00944, D04966 D04966 💬 |
PRKAA1 2件: PRKAA1, PRKAA2 💬 |
AMPK signaling pathway 19件: AMPK signaling pathway, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway |
002 21件: 2 , 6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬 |
54 |
Methylprednisolone |
Methylprednisolone |
6件: D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
002 44件: 2 , 6 , 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 63, 64, 65, 66, 83, 84, 86, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296 💬 |
55 |
Methylthioninium |
Methylthioninium |
- |
- |
- |
127 1件: 127 💬 |
56 |
Methylthioninium chloride |
Chloride ion |
2件: D02312 D02312, D10537 D10537 💬 |
- |
- |
127 1件: 127 💬 |
57 |
Mtc trx0014-001 capsules |
- |
- |
- |
- |
127 1件: 127 💬 |
58 |
N,n,n',n'-tetramethyl-10h-phenothiazine-3,7-diaminium bis(methanesulfonate) |
Phenothiazine |
1件: D02601 D02601 💬 |
- |
- |
127 1件: 127 💬 |
59 |
N,n,n?,n?-tetramethyl-10h-phenothiazine-3,7-diaminium bis(methanesulfonate) |
Phenothiazine |
1件: D02601 D02601 💬 |
- |
- |
127 1件: 127 💬 |
60 |
N,n,n’,n’-tetramethyl-10h-phenothiazine-3,7-diaminium bis(methanesulfonate) |
Phenothiazine |
1件: D02601 D02601 💬 |
- |
- |
127 1件: 127 💬 |
61 |
Neurohormonal mechanisms |
- |
- |
- |
- |
006 2件: 6 , 127 💬 |
62 |
Novolin-r insulin |
- |
- |
- |
- |
127 1件: 127 💬 |
63 |
Other: 13c6 leucine |
Leucine |
1件: D00030 D00030 💬 |
- |
- |
005 3件: 5 , 7 , 127 💬 |
64 |
Other: mri |
- |
- |
- |
- |
006 3件: 6 , 127, 206 💬 |
65 |
Oxytocin |
Oxytocin |
1件: D00089 D00089 💬 |
OXTR 1件: OXTR 💬 |
Calcium signaling pathway 4件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway |
006 5件: 6 , 127, 193, 206, 226 💬 |
66 |
Pea-lut |
- |
- |
- |
- |
127 1件: 127 💬 |
67 |
Phenothiazine |
Phenothiazine |
1件: D02601 D02601 💬 |
- |
- |
127 1件: 127 💬 |
68 |
Pittsburgh compound b |
Pittsburgh Compound B |
- |
- |
- |
006 2件: 6 , 127 💬 |
69 |
Pittsburgh compound b (c-11 pib) |
Pittsburgh Compound B |
- |
- |
- |
127 1件: 127 💬 |
70 |
Pr006 |
- |
- |
- |
- |
127 1件: 127 💬 |
71 |
Prednisone |
Prednisone |
1件: D00473 D00473 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
002 47件: 2 , 6 , 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 81, 84, 85, 86, 93, 95, 96, 97, 113, 127, 162, 164, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331 💬 |
72 |
Procedure: brain pet scan |
- |
- |
- |
- |
005 3件: 5 , 7 , 127 💬 |
73 |
Saline nasal mist |
- |
- |
- |
- |
127 1件: 127 💬 |
74 |
Sirolimus |
Sirolimus |
1件: D00753 D00753 💬 |
MTOR 1件: MTOR 💬 |
AMPK signaling pathway 50件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway |
006 35件: 6 , 13, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 89, 98, 127, 137, 157, 158, 192, 222, 277, 278, 279, 280, 281, 283, 285, 331 💬 |
75 |
Syntocinon |
- |
- |
- |
- |
006 3件: 6 , 127, 193 💬 |
76 |
T807 |
- |
- |
- |
- |
127 1件: 127 💬 |
77 |
Tau (18-f-av-1451) |
- |
- |
- |
- |
127 1件: 127 💬 |
78 |
Tolcapone |
Tolcapone |
1件: D00786 D00786 💬 |
COMT 1件: COMT 💬 |
Dopaminergic synapse 4件: Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism |
006 3件: 6 , 28, 127 💬 |
79 |
Trx0237 |
- |
- |
- |
- |
127 1件: 127 💬 |
80 |
Vizamyl |
- |
- |
- |
- |
005 3件: 5 , 7 , 127 💬 |
81 |
Vizamyl (flutemetamol(f-18)) |
Flutemetamol |
- |
- |
- |
005 3件: 5 , 7 , 127 💬 |